Engaging Thought Leadership
Over 75 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
Formulation & Delivery 2025
13 - 14 May 2025 | Basel, Switzerland
Enabling the swift progression of complex, alternative drug formats to market through safe, effective & targeted formulation and delivery strategies
Formulation & Delivery 2025
Meet Our Expert Speakers
The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Formulation & Delivery 2024: 25 - 26 April 2024, London, UK
Declan Lowney
Director of Stability Sciences,
Janssen R&D
.jpg?length=600&name=cf670826-ae2e-4739-bb29-ca66e1a1a8a5-2-11764368speaker_photo-KajsaRa%C3%8C%C5%A0devik_LowRes-9221-(2).jpg)
Kajsa Rådevik
Associate Director CMC Regulatory Affairs,
AstraZeneca
Naila El Kechai
Head of Biologics Formulation,
Sanofi
Paul Marshall
Regulatory Affairs Director,
Jazz Pharmaceuticals
Sam Nash
Associate Principal Scientist,
AstraZeneca
Amal Ali Elkordy
Professor,
University of sunderland
Andrew Feilden
Director Analytical Science,
Bicycle TX
Annette Vinther Heydenreich
Principal Scientist,
Symphogen
Ben Forbes
Professor of Pharmaceutics,
King's College London
Cees Van Rijn
Professor,
University of Amsterdam
Charley Wu
Professor of Chemical Engineering,
University of Surrey
Chris Broomell
Head of Analytical Development,
Omega Therapeutics
Chris Cardon
Founder Ziphius Vaccines,
Ziphius Vaccines
Christopher Locher
Chief Executive Officer,
Versatope Therapeutics
Covadonga Paneda
Chief Operating Officer,
Altamiratherapeutics
Dan Bach Kristensen
Scientific Director,
Symphogen
Daniel Tondera
Head of Biology,
Pantherna Therapeutics GmbH
David Workman
Associate Principal Scientist,
AstraZeneca
Elena Sanna
Associate Principal Scientist,
Sixfold Bioscience
Elizabeth Ogden
Process Engineer,
AstraZeneca
Estelle Beguin
Director Technology Research,
Ethris GmbH
Florian Rosenthal
Senior Scientist,
F. Hoffman - La Roche Ltd.
Hyunhong James Min
Senior Scientist,
University of Oxford
Ijeoma Uchegbu
Professor of Pharmaceutical Nanoscience,
University College London
Ildikó Terebesi
Managing Director,
INVITE
Janis Shute
Scientific Director,
University of Portsmouth
Jens Twellmeyer
Associate Director Science & Technology,
Novartis AG
Jérôme Mantanus
Head of Materials Science,
UCB Pharma
Jonathan Reid
Professor of Physical Chemistry and Director of the EPSRC,
University of Bristol
Juha Monkare
Sr. Scientist,
J&J
Kamalinder K Singh
Professor of Pharmaceutical Technology and Drug Delivery,
University of Central Lancshire
Koen Raemdonck
Professor,
Ghent University
Mahnoush Bahjat
Associate Director,
AatraZeneca
Martinus Capelle
Scientific Director,
Johnson & Johnson
Maurits Kleijnen
Head of Research,
Intract Pharma
Meike Harms
Lead Scientist,
Merck Healthcare KGaA
Nagy Habib
Lead Clinician and Head of the Department,
Imperial College London
Nathalie Wauthoz
Professor,
Universite Libre de Bruxelles
Per-Olof Wahlund
Specialist,
Novo Nordisk A/S
Philip Rye
Chief Scientific Officer,
AlgiPharma AS
Richard Storey
Principal Scientist,
AstraZeneca
Rikke Dueholm
Senior Scientist,
AstraZeneca
Shayoni Dutta
Principal Data Scientist,
GSK
Simone Vecchi
Cmc leader,
Jnj
Sophie Janbon
Director,
AstraZeneca
Stephen Pham
Senior Vice President,
Avalyn Pharma Inc.
Sune Andersen
Associate Director,
Janssen Pharmaceuticals
Supriyadi Hafiz
Senior Scientist,
Merck Life Science KGaA
Tjasa Vrlinic
PI,
Medincell
Venkatesh Teja Banala
Biopharmaceutics Investigator,
GSK
Vincent Ling
Senior Director,
Takeda Pharmaceuticals
Yngve Mikkelsen
Chief Marketing Officer,
AlgiPharma
Yogeshwar Bachhav
Director,
AiCuris Anti-infective Cures AG
Meet Our Esteemed Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Sponsors of Formulation & Delivery 2024 included
Adare Pharma Solutions
Network & Programme Sponsor
Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Adare’s specialized technology platforms provide taste masking, customized release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare's seven facilities in the US and Europe have developed and manufactured more than 65 products sold by customers worldwide.
Advanced Instruments
Platinum Sponsor
Advanced Instruments is a global provider of scientific and analytical solutions for the biopharma and clinical industries Our company’s innovations have helped organizations improve quality, achieve reliable outcomes, and increase productivity for more than 65 years. Our focus on service, quality, and reliability has made us a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries. Our newest addition, the Artel portfolio, includes leading analytical instruments, software and services that validate, automate, and calibrate critical liquid handling processes and instrumentation. Our Solentim portfolio delivers best-in-class imaging and single-cell deposition technologies for cell line development workflows. And our OsmoTECH® and OsmoPRO® micro-osmometers support the workflows that labs worldwide rely on for the delivery of accurate and timely results.
Aprecia Pharmaceuticals
Network & Programme Sponsor
Aprecia is the leader in the development and manufacturing of 3D printing (3DP) for the pharmaceutical industry. Our commercial scale 3DP platforms and systems transform the way medicine is developed, manufactured, and delivered. We handle complex dosage forms, going beyond the limitations of traditional formulation and manufacturing methods. Applications include: ultra low-dose to ultra high-dose, fixed dose combinations, modified release, rapid orodispersible, potent compounds, etc.
BioDuro-Sundia
Silver Sponsor
Embark on a transformative journey with BioDuro-Sundia, an esteemed Advent International portfolio company with over 28 years of expertise in contract research development, and manufacturing. As a trusted leader in the industry, we are dedicated to providing fully integrated services, guiding our biotech and pharmaceutical partners seamlessly from target identification through to commercial drug product manufacturing. Key Strengths: Comprehensive Services: Our one-stop-shop operation encompasses small and large molecule discovery, development, and scale-up, bolstered by support for IND submission. We offer end-to-end solutions to accelerate your drug development journey. Cutting-Edge Technology: Explore our unique technology platforms, including bioavailability enhancement of insoluble compounds. Specialized techniques such as Amorphous Solid Dispersion using Hot Melt Extrusion and Spray Drying set us apart, ensuring innovative solutions for your formulation challenges. Global Presence: Headquartered in Irvine, California and with a workforce of 3,000 employees and operations in the US and China, spanning 7 global sites across 6 cities, BioDuro-Sundia seamlessly integrates global expertise to serve you better. Accelerated Development: Our science-driven, customer-oriented, flexible, and people-focused culture enables us to provide top-tier, integrated, fast, and flexible tailored services. We are committed to meeting your unique needs and accelerating your development timeline. Highest Standards: Adhering to the highest global standards of compliance and business operation codes, we ensure a secure and transparent partnership. Our Specialized Capabilities Include: Oral solid products (Tablet, Mini-tablet, and Capsule) formulation Analytical and process development CTM (Phase I/II) and Phase III/Commercial Manufacturing Expertise in Amorphous Solid Dispersion using Hot Melt Extrusion and Spray Drying Modified Release (IR, DR, and CR) formulations Discover the BioDuro-Sundia advantage and revolutionize your drug product development journey. Visit our website at www.bioduro-sundia.com for more information.
Celanese
Silver Sponsor
Celanese works closely with you as a strategic partner to create innovative controlled-release dosage forms for biologics and small molecules to meet the goals of patient-centric therapies, improved medicine and better healthcare economics. Our VitalDose® EVA copolymer drug-delivery platform is an enabling technology for drug-eluting implants, inserts and transdermal films. The platform is flexible and customizable to address a variety of formulation challenges when it comes to tailoring the release rate of your drug. VitalDose® EVA is compatible with biologics and small molecules, provides reliable local or systemic drug administration, demonstrates high drug loading capacity (≤ 75%) and can be engineered for long-acting dosage profiles (zero-order or nonlinear profiles). VitalDose® EVA offers ease of formulation and is configurable into a variety of geometries. With long clinical use history and an established regulatory path, Celanese is able to address challenges with a proven platform for effective delivery of molecules at both a systemic and localized level. From feasibility to development to commercialization, our scientists and engineers are with you from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support.
Croda Pharma
Gold Sponsor
Croda Pharma is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations. The company is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid delivery platforms. With a wide range of solutions for both human and animal health markets, the pharmaceutical portfolio is unsurpassed in its excellence. Croda Pharma’s products, along with its in-house formulation and regulatory expertise, allows the company to meet its customers’ most demanding formulation needs. The company is committed to enabling the next generation of drug delivery systems.
Evonik
Bronze Sponsor
Evonik is one of the world’s leading specialty chemical companies. Our broad, versatile portfolio of functional excipients, technologies and CDMO services for oral and parenteral dosage forms makes us a global leader for advanced drug delivery. We also serve as a global CDMO for small molecule APIs, HPAPIs and intermediates, and supply high-quality, innovative cell culture solutions and amino acids. Evonik operates a trusted global network of manufacturing sites, laboratories and development centers around the world. We have a track record of providing enabling solutions to more than 1,000 pharmaceutical, med-tech and nutraceutical customers worldwide, including 90% of the world’s top life-science companies.
Innocore Pharmaceuticals
Bronze Sponsor
InnoCore is a drug delivery company which has developed its proprietary biodegradable drug delivery technologies. Its specialized in the development of novel injectable biodegradable polymer based pharmaceutical drug delivery systems (implants, microspheres, hydrogels, in-situ forming implants and stent coatings) for small molecules, peptides, oligonucleotides and proteins.
Lonza
Silver Sponsor
At Lonza Small Molecules, our connected experts work together to provide contract development and manufacturing services, helping pharma and small biotech companies deliver their medicines to patients in need. From the earliest stages of discovery to the final drug product, we can simplify your outsourcing experience with our reliable, timely service, anticipating risks and solving problems. Whether you are developing a pioneering therapy or creating a new oral solid dosage form, Lonza is the only CDMO partner you need. Throughout your molecule’s journey from early development to commercial product, we work as one. https://www.lonza.com/small-molecules
Merxin
Network & Programme Sponsor
Merxin Ltd designs and supplies inhaler devices, dry powder inhalers and soft mist inhalers. We work with biologics, small molecules, generic, and novel therapies. We create, develop and supply inhaler devices for evaluation through to commercial supply. Merxin Ltd’s inhalers save customers money and time to develop, file and market inhaled dosage forms. We take problems away from our customers. We are part of the solution. Our DNA is in the pharma industry: we deliver quality, reliability and efficacy. The Merxin Ltd team has a thorough understanding and long history of medical device and pharmaceutical product development. Our reputation is built on excellence and audacity. Quality is in our veins. We have been assessed and certified as meeting the requirements of ISO 13485:2016 for the Design, Development and Supply of inhalers. We believe in Quality, we deliver Reliability. Established in the UK in 2015 and based in King’s Lynn, we have manufacturing capacity across the globe and an international client base. Our products are: MRX002+: a PET vial used to model pMDI formulations in situ;MRX003: a world-leading capsule dry powder inhaler, approved and marketed;MRX004: a fully developed and clinic-ready soft mist inhaler;MRX006: a dual-cavity multi-dose dry powder inhaler.
Munit SA
Network & Programme Sponsor
MUNIT is operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics. In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy). Our services: • Jet- , Pin- and Hammer milling • Cryogenic Micronization • Co- micronization • Sieving, Blending, De-Lumping • Technical trials, DoE Studies, Process development and validation • QbD • PSD analysis etc.
NanoFCM
Silver Sponsor
Achieve fast, quantitative measurement of LNPs and their RNA cargo by nano-flow cytometry (nFCM) at the single particle level. NanoFCM is a leading provider of dedicated particle characterization instruments allowing for sizing and concentration measurements of the LNPs with simultaneous assessment of RNA cargo to determine empty/loaded ratios, quantification of mRNA/saRNA copy numbers, and encapsulation efficiency. Acquire the NanoAnalyzer to expand your own capabilities or utilize NanoFCMs unique expertise through our CRO service.
NextPharma Goettingen
Network & Programme Sponsor
At NextPharma, we provide a full range of pharmaceutical services from early-phase to commercialisation including formulation development, clinical trials and analytical services, commercial manufacturing and packaging across a broad range of pharmaceutical dosage forms. Our 10 sites are established 'Centres of Excellence' for each specific dosage form(s), with knowledgeable and experienced teams driving a science-led decision making process, ensuring the manufacture of high quality drug products. Our vision is to be the most trusted, reliable and innovative European CDMO by upholding the highest industry standards and exceeding customer expectations.
NOF Europe GmbH
Network & Programme Sponsor
NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators.
Onyx Scientific
Network & Programme Sponsor
Onyx Scientific is the CDMO division of Ipca Laboratories. Our MHRA-licensed sites in the UK specialise in offering an integrated solid form, preformulation, crystallisation and chemical development service that facilitates manufacture of candidate APIs for clinical phases through to commercial supply. Our dedicated teams expedite development activities at Onyx but are also available to provide full-service outsourced projects to complement or support your in-house campaigns. With a wealth of early development experience and success, our pragmatic, fit-for-purpose approach focuses on rapid process development and a view to future GMP campaigns. Where required, scale-up through Phase II towards commercial manufacture is retained either at Onyx or within the Group through transfer to our sister sites and colleagues in the USA and India.
Pfanstiehl GmbH
Bronze Sponsor
Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose and Amino Acids such as L-Arginine, Histidine, Glutamine, Tris base, Tris HCl and Methionine for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities
Pion
Bronze Sponsor
Pion offers unique instruments and services designed to empower scientists in making informed decisions throughout the entire lifecycle of food and drug formulation, spanning from Research and Development (R&D) to Manufacturing. Our commitment lies in assisting users to gain a comprehensive understanding of critical properties such as dissolution, solubility, permeation, ionization, and absorption of their compounds and drug products. Additionally, we provide dependable and consistent process solutions tailored for R&D purposes, as well as sample preparation solutions for content uniformity, analytical, and mixing testing. Pion stands as a supportive partner in research endeavors, delivering scientific instruments, analytical services, and equipment that ensure the precision of results needed for more predictive decision-making within the drug development process.
Qualicaps
Silver Sponsor
With over 125 years of dedicated experience in capsule manufacturing, Qualicaps is a stalwart in the industry, offering unparalleled expertise to enhance patient health outcomes. Qualicaps is committed to delivering pharmaceutical-grade hard-two-piece capsules meticulously crafted to meet the exacting standards of the pharmaceutical industry. Backed by a global team of commercial, scientific, and technical experts, we provide comprehensive services throughout the product life cycle. As a responsible company, we take pride in each capsule we produce, ensuring they offer precise and optimal solutions for drug delivery challenges and overall health and well-being. At Qualicaps, we strive to contribute meaningfully to the advancement of healthcare, guided by our unwavering dedication to quality and innovation.
Reading Scientific Services Ltd
Network & Programme Sponsor
Reading Scientific Services Limited (RSSL) is a world leader in providing high-quality scientific analysis, research, consultancy and training solutions to the global Life Science, Pharmaceutical, Biopharmaceutical, Healthcare and Personal care sectors. From our state-of-the-art facilities in Reading, UK, our multi-disciplinary team of >300 scientists work hand-in-hand with our clients to develop drug products that are safe, innovative and capable of transforming lives around the world. We offer a diverse range of biological, microbiological, chemical and physical analytical services across all phases of clinical development through to commercial release. We also provide and bespoke training and consultancy solutions. RSSL is MHRA and FDA approved.
RedShift BioAnalytics Inc
Bronze Sponsor
RedShiftBioⓇ is a forward-thinking technology company providing novel life science analytical platforms, reagents, software, and services to leading biopharmaceutical companies and research laboratories. The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS), that provides in-depth biomolecule structural information in a single automated analysis. RedShiftBio also offers the HaLCon Analyzer, a fit-for-purpose protein analyzer designed to provide easy and accurate protein titer measurements at the point of need. RedShiftBio is headquartered in Boxborough, Massachusetts.
Sever Pharma Solutions
Bronze Sponsor
Sever Pharma Solutions, a CDMO providing our customers with unique capabilities and expertise in extrusion Polymer based dosage forms including HPAPI’s. We efficiently provide a complete value chain for an optimized end-to-end solution. We are Hot Melt Extrusion. We are Polymer Based Dosage Forms. We are Formulation of HPAPI dosage forms. We are Long-Acting Implants. We are Solid Dosage Forms. We are Injection Molding. We are Controlled Substance dosage forms. We are Aseptic Fill and Finish. We are Sever Pharma Solutions and we bring your pharmaceutical ideas to life.
SGS Quay Pharmaceuticals
Network & Programme Sponsor
Our Global Center of Excellence for Formulation and Clinical Manufacturing in the UK provides enhanced formulation research and development services for phase I, phase II, and phase III trials. Preclinical Formulation Screening We provide a structured pre-formulation pathway to ensure the efficient screening of lead candidates, maximizing the dose that can be administered and is available for absorption. Formulation Development Pharmaceutical development and dosage form optimization for a wide range of product types, including those that have poor solubility or bioavailability. Clinical Manufacturing We offer a comprehensive range of clinical manufacturing services to help ensure your drug product uses the right delivery approach. With MHRA and FDA inspected facilities, we are licensed to manufacture non-sterile Phase I to III medicines.
.png?length=600&name=MicrosoftTeams-image%20(66).png)
Trelleborg Healthcare & Medical
Silver Sponsor
Trelleborg Medical Solutions helps pharmaceutical and medical device companies working on sustained-release drug delivery products. These therapies are implantable systems formulated with an excipient polymer that can deliver active ingredients for months or years in a single dosage. As a contract development and manufacturing partner, we apply our expertise in polymers to accelerate our customers toward a product concept that meets patient needs. Once the concept is developed, our team then supports through the challenge of scaling these processes up to produce clinical product and develop the plan to support marketed product as well. Our background in medical devices also allows us to support any needs for companion devices that go along with many of these combination products. Our team is able to apply our expertise across all required disciplines to produce finished product and support throughout the entire supply chain, allowing us to be a critical partner in our customer's go-to-market strategies.
Unchained Labs
Network & Programme Sponsor
Here’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
XtalPi
Silver Sponsor
XtalPi is a global technology platform company powered by artificial intelligence (AI) and robotics. Founded in 2014, XtalPi is dedicated to driving intelligent and digital transformation in life sciences and discovering better therapeutics and new materials. By integrating and synergizing quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of innovative solutions, services, and products to empower our partners in the biopharmaceutical, chemical, new energy, and new materials sectors worldwide.
Yirdoc (Qingdao Future Medical Technology Co.)
Network & Programme Sponsor
Yirdoc is a leading provider of customized mesh nebulizers for inhalation delivery needs. Our patented nebulizer design, mesh technology, and digital platform are designed to improve clinical results and formulation development by increasing the total dose delivered. As a trusted partner to pharmaceutical and biopharmaceutical companies, Yirdoc helps its clients achieve their goals by providing innovative solutions that meet their specific needs. Whether you're looking to improve drug delivery or optimize formulation development, Yirdoc has the expertise and technology to help you succeed. Yirdoc is a leading provider of customized mesh nebulizers for inhalation delivery needs. We focus on developing formulation-specific solutions and our mesh technology and digital platform are designed to improve clinical results and formulation development. As a trusted partner to pharmaceutical and biopharmaceutical companies, Yirdoc currently works with both small molecules and biologics to provide cost-effective and formulation-specific solutions. Whether you're looking to improve inhalation delivery or optimize inhalation clinical outcomes, Yirdoc has the expertise and technology to help you succeed.
Exolvo Biosciences' Approach to Advancing Oral Biologics Drug Delivery
NLC Health Ventures collaborates with Verily, a precision health tech company, to launch Exolvo Biosciences: an up-and-coming biotech delivering next generation solution for biologics drug delivery.
CRISPR 2.0 - Improving Drug Delivery Through Ultracompact CRISPR Systems
New genome editing methods are building on the capabilities of CRISPR/Cas9. The CasMINI is the latest technology that aims to safely and efficiently deliver genetic therapies to patients.
Enhancing Drug Stability & Exploring Novel Formulation Strategies
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Formulation & Delivery UK 2024
Innovative Foam Technology Enhances Gene Therapy Delivery
Researchers at the Fred Hutch Cancer Center conducted a study investigating the potential of medicated foam as a gene therapy delivery vector. Their studies showed that a foam-based delivery system enhances the efficiency and safety of gene therapy by ensuring concentrated, controlled release of therapeutic agents.
Freeze-Drying 2.0: Examining the Potential of Thin Film Freezing
TFF Pharmaceuticals and the Cleveland Clinic team up to advance multivalent influenza vaccine candidates into preclinical phases.
.jpg)
Investigating the Potential of Inhaled Biologics in Treating Idiopathic Pulmonary Fibrosis
Positive results from Aileron Therapeutics' ongoing Phase Ib clinical trial gives hope to patients diagnosed with idiopathic pulmonary fibrosis (IPF).